The most common form of dementia, Alzheimer’s Disease (AD), currently afflicts 5.5 million adults in the United States and is estimated by 2050 to impact 13.8 million (age 65 or older).
Why is this happening?
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
